|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||47.10 - 48.00|
|52 Week Range||42.30 - 69.50|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||46.37|
|Earnings Date||Jul 27, 2023|
|Forward Dividend & Yield||1.02 (2.17%)|
|Ex-Dividend Date||May 31, 2023|
|1y Target Est||80.83|
Subscribe to Yahoo Finance Plus to view Fair Value for COPN.SWLearn more
Readers hoping to buy Cosmo Pharmaceuticals N.V. ( VTX:COPN ) for its dividend will need to make their move shortly, as...
With its stock down 17% over the past three months, it is easy to disregard Cosmo Pharmaceuticals (VTX:COPN). However...
Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly...
With a price-to-earnings (or "P/E") ratio of 53.2x Cosmo Pharmaceuticals N.V. ( VTX:COPN ) may be sending very bearish...
Medtronic's (MDT) GI Genius intelligent endoscopy module is the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.
If you want to know who really controls Cosmo Pharmaceuticals N.V. ( VTX:COPN ), then you'll have to look at the makeup...
Most readers would already be aware that Cosmo Pharmaceuticals' (VTX:COPN) stock increased significantly by 20% over...
Cosmo Pharmaceuticals N.V. ( VTX:COPN ) shareholders should be happy to see the share price up 20% in the last month...